RUA Life Sciences has provided an update on the progress of its vascular graft and vascular patch products, under development within RUA Vascular. Initial observations of the graft performance are encouraging and despite some external COVID-19 related delays, the grafts remain on track for US 510k regulatory filing in Q2/21E. This timing remains in-line with our expectation of US clearance during H2/21E. Development work on the patches has identified additional commercial opportunities for these ....
30 Mar 2021
Cenkos: RUA Life Sciences Plc -- RUA Vascular update
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: RUA Life Sciences Plc -- RUA Vascular update
RUA Life Sciences Plc (RUA:LON) | 11.0 -0.1 (-4.3%) | Mkt Cap: 6.83m
- Published:
30 Mar 2021 -
Author:
Chris Donnellan -
Pages:
5
RUA Life Sciences has provided an update on the progress of its vascular graft and vascular patch products, under development within RUA Vascular. Initial observations of the graft performance are encouraging and despite some external COVID-19 related delays, the grafts remain on track for US 510k regulatory filing in Q2/21E. This timing remains in-line with our expectation of US clearance during H2/21E. Development work on the patches has identified additional commercial opportunities for these ....